Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines1
- 1 October 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (10), 2122-2129
- https://doi.org/10.1002/ibd.21601
Abstract
Inflammatory bowel disease (IBD) patients have increased prevalence of osteoporosis, leading to guideline recommendations for bone mineral density (BMD) testing. The study aim was to identify predictors of BMD testing and treatment and assess guideline effectiveness to identify IBD patients with osteoporosis. Records of all IBD patients at seven medical facilities were reviewed for clinical data and BMD testing from January 1996 through October 2006. A total of 2035 patients had 317 bone density tests performed. Osteopenia was found in 48% of patients, osteoporosis in 26%. Among patients meeting guideline criteria for BMD testing and ≥1 year of follow-up, 23.3% underwent testing. The strongest predictors of testing were menopause (adjusted hazard ratio [AHR] 3.02) and receiving care at a tertiary center (AHR 2.56). Testing rates were low in patients with age ≥60 years, ulcerative colitis, and a history of inpatient IBD treatment. Osteoporotic patients received calcium/vitamin D and bisphosphonates in 59% and 75% of cases, respectively. Osteoporotic males had a 37% rate of hypogonadism. Guideline criteria do not distinguish patients with osteoporosis. The criteria had a sensitivity, specificity, positive predictive value, and negative predictive value of 84%, 23%, 27%, and 81% for osteoporosis in the tested population, respectively. Osteoporosis is highly prevalent in the IBD population, but BMD testing and osteoporosis treatments are underutilized. Male hypogonadism is common in osteoporotic IBD patients. Guidelines do not identify IBD patients with osteoporosis.Keywords
This publication has 38 references indexed in Scilit:
- Analysis of Risk Factors for Low Bone Mineral Density in Inflammatory Bowel DiseaseDigestion, 2006
- Glucocorticoid-Induced Osteoporosis: From Basic Mechanisms to Clinical AspectsNeuroimmunomodulation, 2005
- Adherence with osteoporosis practice guidelines: A multilevel analysis of patient, physician, and practice setting characteristicsAmerican Journal Of Medicine, 2004
- Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort studyGut, 2004
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- Fracture risk is increased in Crohn's disease, but not in ulcerative colitisGut, 2000
- Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracturesBMJ, 1996
- A controlled study of bone mineral density in patients with inflammatory bowel disease.Gut, 1995
- Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosisJournal of Bone and Mineral Research, 1995
- Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection.Gut, 1977